MRPL28 Recombinant Antibody, Cy3 Conjugated
Product Specifications
Background
Potentially represents an important therapeutic reagent for HLA-A24 patients. This antigen is recognized by tumor-infiltrating lymphocyte (TIL) 1290 in the context of HLA-A24.
Synonyms
L28mt; MAAT1; mrpl28; P15.
Gene ID
10573
Swiss Prot
Q13084
Cellular Locus
Cytoplasm
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Target
MRPL28
Clonality
Recombinant
Conjugation
Cy3
Source
KLH conjugated synthetic peptide derived from human MRPL28
Applications
WB, Flow-Cyt
Purification
Purified by Protein A.
Excitation Emission
512,550nm/570,615nm
Concentration
Lot dependent
Dilution
WB (1:300-5000), Flow-Cyt (1ug/Test)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
10573
Isotype
IgG
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
126023-ML750 100 µL
DRF1 (ASKL1, Protein DBF4 Homolog B, Activator of S Phase Kinase-like Protein 1, Chiffon Homolog B, Dbf4-related Factor 1, FLJ13087, MGC15009) (MaxLight 750) discontinued
Ask
View Details GTR15123725 1 Vial
Lentiviral human ARSL shRNA (UAS) - Lentiviral human ARSL shRNA (UAS) (25)
Ask
View Details